Welcome to our dedicated page for CARTERS SEC filings (Ticker: CRI), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on CARTERS's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into CARTERS's regulatory disclosures and financial reporting.
Carter’s Inc. (CRI) – Form 4 insider filing
Director Jevin Eagle reported a small automatic acquisition of company stock under the board’s deferred-compensation program. On 20 Jun 2025, Eagle received 14.8783 shares of common stock at $0.00 (stock dividend reinvestment). His direct holdings rose to 22,697.0112 shares following the credit. The transaction is coded “A” (acquisition) and was executed without a 10b5-1 trading plan designation.
The filing reflects routine dividend accrual rather than an active purchase or sale, and the share amount is immaterial relative to Carter’s average daily volume and the director’s existing stake. No derivative securities or additional transactions were disclosed.
Carter's (NYSE:CRI) director Hali Borenstein filed a Form 4 disclosing the automatic acquisition of 14.8783 common shares on 06/20/2025 at $0.00 per share under the company’s director deferred-compensation program. The dividend-equivalent credit raised her directly held balance to 16,975.0112 shares.
No open-market purchases, sales, or derivative transactions were reported, and the filing contains no other material disclosures or amendments. The transaction appears routine and is not tied to a Rule 10b5-1 trading plan.